{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:02:41Z","timestamp":1772830961137,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jocn.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T08:14:11Z","timestamp":1594109651000},"page":"318-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Clinical, MRI and 18F-FDG-PET\/CT analysis of progressive supranuclear palsy"],"prefix":"10.1016","volume":"80","author":[{"given":"Ping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.06.008_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2020.06.008_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11910-018-0819-5","article-title":"Progressive supranuclear palsy: an update","volume":"18","author":"Armstrong","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jocn.2020.06.008_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.parkreldis.2016.12.023","article-title":"Advanced structural neuroimaging in progressive supranuclear palsy: where do we stand?","volume":"36","author":"Stezin","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"10.1016\/j.jocn.2020.06.008_b0020","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1212\/01.WNL.0000052991.70149.68","article-title":"Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study","volume":"60","author":"Nath","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2020.06.008_b0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy - the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jocn.2020.06.008_b0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","article-title":"Globular glial tauopathies (GGT): consensus recommendations","volume":"126","author":"Ahmed","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.jocn.2020.06.008_b0035","article-title":"Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?","volume":"33","author":"Kuiperij","year":"2012","journal-title":"Neurobiol AgingNeurobiol Aging"},{"key":"10.1016\/j.jocn.2020.06.008_b0040","doi-asserted-by":"crossref","unstructured":"Adam L. Boxer, Jin-Tai Yu, Lawrence I. Golbe, et al. New diagnostics and therapeutics for progressive supranuclear palsy. Lancet Neurol 2017;16(7):552\u201363.","DOI":"10.1016\/S1474-4422(17)30157-6"},{"key":"10.1016\/j.jocn.2020.06.008_b0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mds.25327","article-title":"Accuracy of the National Institute for Neurological Disorders and Stroke\/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy","volume":"28","author":"Respondek","year":"2013","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2020.06.008_b0050","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.parkreldis.2015.09.041","article-title":"The phenotypic spectrum of progressive supranuclear palsy","volume":"22","author":"Respondek","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2020.06.008_b0055","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.parkreldis.2004.02.003","article-title":"Caribbean parkinsonism and other atypical Parkinsonian disorders","volume":"10","author":"Eduardo","year":"2004","journal-title":"Parkinsonism Related Disorders"},{"issue":"5","key":"10.1016\/j.jocn.2020.06.008_b0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/nmt.15.37","article-title":"The differentiation of progressive supranuclear palsy","volume":"5","author":"Cordato","year":"2015","journal-title":"Neurodegener Dis Manag"},{"issue":"6","key":"10.1016\/j.jocn.2020.06.008_b0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/nmt-2016-0027","article-title":"Managing cognition in progressive supranuclear palsy","volume":"6","author":"Rittman","year":"2016","journal-title":"Neurodegener Dis Manag"},{"issue":"12","key":"10.1016\/j.jocn.2020.06.008_b0070","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/01.WNL.0000165977.38272.15","article-title":"\u201cApplause sign\u201d helps to discriminate PSP from FTD and PD","volume":"64","author":"Dubois","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jocn.2020.06.008_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jnp.12053","article-title":"Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease","volume":"10","author":"Lopez","year":"2016","journal-title":"Neuropsychol"},{"issue":"2","key":"10.1016\/j.jocn.2020.06.008_b0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/01616412.2018.1541115","article-title":"MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy","volume":"41","author":"Eraslan","year":"2019","journal-title":"Neurol Res"},{"issue":"3","key":"10.1016\/j.jocn.2020.06.008_b0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.33160\/yam.2018.09.001","article-title":"Role of neuroimaging on differentiation of Parkinson's disease and its related diseases","volume":"61","author":"Ogawa","year":"2018","journal-title":"Yonago Acta Med"},{"issue":"14","key":"10.1016\/j.jocn.2020.06.008_b0090","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","article-title":"Typical cerebral metabolic patterns in neurodegenerative brain diseases","volume":"25","author":"Teune","year":"2010","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2020.06.008_b0095","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"10.1016\/j.jocn.2020.06.008_b0100","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1567205015666180507111958","article-title":"Progressive supranuclear palsy: neuropsychopathological, therapeutical and bioethical aspects","volume":"15","author":"Vecchio","year":"2018","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"10.1016\/j.jocn.2020.06.008_b0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","article-title":"Voxel-based morphometry in autopsy proven PSP and CBD","volume":"29","author":"Josephs","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.jocn.2020.06.008_b0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ane.12546","article-title":"Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants","volume":"134","author":"Lopez","year":"2016","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"10.1016\/j.jocn.2020.06.008_b0115","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.WNL.0000068011.21396.F4","article-title":"Atrophy of superior cerebellar peduncle in progressive supranuclear palsy","volume":"60","author":"Tsuboi","year":"2003","journal-title":"Neurology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820313163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820313163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:24:42Z","timestamp":1760822682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820313163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":23,"alternative-id":["S0967586820313163"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.06.008","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, MRI and 18F-FDG-PET\/CT analysis of progressive supranuclear palsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}